AstraZeneca boss ‘wants to shift stock market listing to US’
AstraZeneca’s chief executive, Pascal Soriot, has reportedly said that he would like to shift the company’s stock market listing from…
AstraZeneca’s chief executive, Pascal Soriot, has reportedly said that he would like to shift the company’s stock market listing from…
The drugmaker Indivior has become the latest company to abandon its listing in London, heaping further pressure on the London…